Qube Research & Technologies (QRT)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.8M Sell
70,000
-56,600
-45% -$13.2M 0.02% 971
2026
Q1
$30.9M Sell
126,600
-145,100
-53% -$33.8M 0.03% 634
2025
Q4
$56.2M Buy
271,700
+149,500
+122% +$29.6M 0.06% 440
2025
Q3
$22.7M Sell
122,200
-46,600
-28% -$7.98M 0.02% 835
2025
Q2
$25.8M Sell
168,800
-135,900
-45% -$20.9M 0.03% 751
2025
Q1
$50.5M Buy
304,700
+117,400
+63% +$18.4M 0.06% 405
2024
Q4
$27.1M Sell
187,300
-119,700
-39% -$18.5M 0.04% 591
2024
Q3
$49.8M Buy
307,000
+126,556
+70% +$20.2M 0.07% 348
2024
Q2
$26.4M Buy
180,444
+135,300
+300% +$20.1M 0.04% 512
2024
Q1
$7.14M Buy
45,144
+14,044
+45% +$2.24M 0.01% 1023
2023
Q4
$4.87M Buy
+31,100
New +$4.77M 0.01% 1054

Other funds holding JNJ

Qube Research & Technologies (QRT)'s JNJ Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Johnson & Johnson (JNJ) in Q2 2026: 752,337 shares worth $191M. The stake represents 0.18% of the portfolio and ranks #127 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in JNJ as recently as Q4 2025.

Qube Research & Technologies (QRT) first reported a position in JNJ in Q1 2018 and has held it in 29 quarters since. The position peaked at $570M in Q4 2024. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Qube Research & Technologies (QRT) held 752,337 shares of Johnson & Johnson worth $191M as of Q2 2026.
  • Johnson & Johnson was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Johnson & Johnson made up 0.18% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #127 holding.
  • Qube Research & Technologies (QRT) first reported a position in Johnson & Johnson in Q1 2018 and has held it in 29 quarters since.
  • Qube Research & Technologies (QRT)'s Johnson & Johnson position peaked at $570M in Q4 2024.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.